Xilio Therapeutics is a startup based in the United States, most recent round Series B, 1 tracked investor.
Based in the United States, Xilio Therapeutics is a startup. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Xilio Therapeutics is a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies with the goal of significantly improving outcomes for people living with cancer by selectively activating within the tumor microenvironment to achieve durable efficacy without severe side effects.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.